Bio-Techne TECH Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's accounts payable?
- Bio-Techne (TECH) reported accounts payable of $23.49M in Q1 2026.
- How has Bio-Techne's accounts payable changed year-over-year?
- Bio-Techne's accounts payable decreased by 25.8% year-over-year, from $31.64M to $23.49M.
- What is the long-term trend for Bio-Techne's accounts payable?
- Over 4 years (2021 to 2025), Bio-Techne's accounts payable has grown at a -3.7% compound annual growth rate (CAGR), from $29.38M to $25.31M.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods and services it has already received.
- How do you interpret accounts payable?
- An increase can signal improved cash management or delayed payments, while a decrease may indicate faster settlement of obligations.
- How does accounts payable compare across companies?
- Standard across industries; peers with strong bargaining power often maintain higher payable balances.